ATNM vs DHR · rev $35.0M vs P/E 39, rev $6.26B
Actinium Pharmaceuticals Inc (ATNM) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ATNM currently screens at market cap $33.9M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the ATNM and DHR stock pages for the full models.
Not investment advice.